Advanced Practice Midwife in Lewiston, ME Accepting Medicare

10 Advanced Practice Midwife nurses found. Showing 1 - 10

Erica J Richards, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 330 Sabattus St, Lewiston, ME 04240 Phone: 207-777-4300    Fax: 207-755-3021

Heather Georgianna Beveridge, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 300 Main St, Lewiston, ME 04240 Phone: 207-795-0111    Fax: 207-795-2766

Ms. Penny Hauser, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 330 Sabattus Street, Lewiston, ME 04240 Phone: 207-777-4300    Fax: 207-755-3021

Kristin Moody, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 12 High St Ste 200, Lewiston, ME 04240 Phone: 207-795-5770

Jane E Mills, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 12 High St, Ste 200, Lewiston, ME 04240 Phone: 207-795-5770    Fax: 207-795-5779

Jade Mangiafico, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 300 Main St, Lewiston, ME 04240 Phone: 207-795-0111

Mrs. Emilie Garcia, MSN, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 12 High St, Suite 200, Lewiston, ME 04240 Phone: 207-795-5770    Fax: 207-795-5779

Ms. Aleta Joy, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 12 High St Ste 200, Lewiston, ME 04240 Phone: 207-795-5770    Fax: 207-795-5779

Ms. Chris I Gillis, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 330 Sabattus Street, Lewiston, ME 04240 Phone: 207-777-4300    Fax: 207-755-3021

Caitlin R Sloan, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 330 Sabattus St, Lewiston, ME 04240 Phone: 207-777-4300    Fax: 207-755-3021

News Archive

ULURU reports Altrazeal clinical trial results

ULURU Inc. (NYSE Alternext: ULU) announced today the presentation of results from the first completed randomized clinical trial for Altrazeal at the SAWC Fall symposium in Washington D.C. September 16-18. The recently completed clinical study compared healing, pain and comfort of skin graft donor sites treated with either Altrazeal(TM) or with a leading commercial sodium carboxymethylcellulose-silver ("CMC-Ag") dressing.

Study uses precision medicine approach to find effective treatments for rare cancers

For the first time, researchers have been able to identify effective treatments for patients with rare cancers by analyzing genes and proteins in their blood and tumors. In a study reported in The Oncologist, half the patients receiving these targeted treatments saw their rare cancers either stabilize, shrink or go into remission.

Amicus Therapeutics presents positive results from phase 2 extension study of Amigal for Fabry disease

Amicus Therapeutics has announced positive results from its ongoing Phase 2 extension study of its investigational drug, Amigal (migalastat HCL) for Fabry disease.

Mutations in gene protecting body leads to development of cancer

An important gene that normally protects the body against cancer can itself cause a variety of cancers depending on the specific mutation that damages it, according to a new study by investigators at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James).

Read more Medical News

› Verified 4 days ago